![saxenda glp 1 agonist Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States WEIGHT LOSS DRUGS – DO](https://photos.prnewswire.com/prnfull/20150421/200096)
saxenda glp 1 agonist Novo Nordisk announces Saxenda® (liraglutide [rDNA origin] injection) is now commercially available in the United States WEIGHT LOSS DRUGS – DO
Description
Anker MS, Lck LC, Khan MS, et al
![saxenda glp 1 agonist Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States WEIGHT LOSS DRUGS DO](https://cdn.shopify.com/s/files/1/0572/0519/4786/products/saxenda-5-pen-pack-832426_480x480.jpg?v=1664644195)
Neuroinflammation reduction
![saxenda glp 1 agonist Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States WEIGHT LOSS DRUGS DO](https://www.rivasweightloss.com/wp-content/uploads/2024/05/glp-1-banner.png)
The anti-inflammatory and immunological properties of GLP-1 receptor agonists
![saxenda glp 1 agonist Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States WEIGHT LOSS DRUGS DO](https://www.singlecare.com/blog/wp-content/uploads/2026/01/saxenda-generic-1884x1060.png)
Peripheral insulin and amylin levels in Parkinsons disease
![saxenda glp 1 agonist Novo Nordisk announces Saxenda (liraglutide [rDNA origin] injection) is now commercially available in the United States WEIGHT LOSS DRUGS DO](https://cdn.sanity.io/images/0vv8moc6/patientcare/052b80bee14aa88c8bc23d0d2186358e8982b16f-674x541.jpg)
